Inmune Bio director Clark Ronnie Duane received 100,000 derivative securities on September 15, establishing a resulting holding of 100,000 securities. The transaction matters to investors because it represents 100.0% of his resulting derivative-securities position and marks a new insider position at the biotechnology company.
Key Highlights
- Clark Ronnie Duane received 100,000 derivative securities from Inmune Bio on September 15, 2026.
- The director’s resulting holding stood at 100,000 derivative securities.
- The award represented 100.0% of Clark Ronnie Duane’s resulting derivative-securities total.
Inmune Bio, Inc. (NASDAQ: INMB), a biotechnology company, awarded director Clark Ronnie Duane 100,000 derivative securities on September 15, 2026. Clark’s post-transaction holding was 100,000 derivative securities in Inmune Bio. The award itself accounted for 100.0% of that resulting total. Clark reported a new insider position at Inmune Bio. The recorded award date was September 15, 2026.
FAQs
Q: How many derivative securities did Clark Ronnie Duane receive from Inmune Bio?
A: Clark Ronnie Duane received 100,000 derivative securities from Inmune Bio. The award was recorded on September 15, 2026.
Q: What was Clark Ronnie Duane’s resulting holding in Inmune Bio?
A: Clark Ronnie Duane’s resulting holding was 100,000 derivative securities in Inmune Bio. The stated total followed the award transaction.
Q: What does transaction code A mean in the Inmune Bio disclosure?
A: Transaction code A identifies an award or grant. In this case, it applied to Clark Ronnie Duane’s award of 100,000 derivative securities.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.